|Articles|September 1, 2001
- Pharmaceutical Executive-09-01-2001
- Volume 0
- Issue 0
Inefficiencies: Cutting Through the Jungle
Author(s)Kevin Gopal
Berlin-The German healthcare system is ailing, and politicians are too timid and inefficient to do anything about it, according to the Verband Forschender Arzneimittelhersteller (VFA), Germany’s pharmaceutical industry trade association.
Advertisement
Articles in this issue
over 24 years ago
Profits and Promotion Under Attackover 24 years ago
New Playing Fieldsover 24 years ago
Legislation: EC Proposes Changesover 24 years ago
Flexing Their Budgets: Big Pharma Spend Trendsover 24 years ago
Media Mix Town Meeting 2001: Much Ado About MediaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
